Metabolic Syndrome

My Settings
Relevant Content
Researchers at Heart
Strategies for Optimizing Heart Failure Care in the Older Adults
Heart failure (HF) in older adults is a growing and distinct clinical chal...
Alterations in Cardiac and Systemic Metabolism in Heart Failure
Circulation: Heart Failure, Ahead of Print.
Altered cardiac and syste...
Vacuolar H+-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging
Circulation, Ahead of Print.
BACKGROUND:Cardiac aging involves progre...
Cost of Idling: Skeletal Muscle Myosin ATPase Dysfunction and the Energetic Basis of Exercise Intolerance in HFrEF
Circulation: Heart Failure, Ahead of Print.
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease
The American Heart Association Predicting Risk of Cardiovascular Disease E...
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Guideline offering updated evidence on cardiovascular‑kidney‑metabolic syn...
Vascular Contributions to Cognitive Impairment and Brain Health
This paper updates the 2011 Vascular contributions to cognitive impairment...
Bile Acids, Mitochondria, and Myocardial Stiffness: A Shared Mechanism in Fontan Circulation and Metabolic Dysfunction-Associated Steatotic Liver Disease
Circulation: Heart Failure, Ahead of Print.
Is Placebo Still Ethical in Trials of Incretin Therapies?
Circulation, Volume 153, Issue 14, Page 1005-1008, April 7, 2026.